The Effects of Transdermal Nicotine for the Treatment of Hispanic Smokers

Scott Leischow, Anabel Hill, Gretchen Cook

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Objective: To assess the efficacy of transdermal nicotine as an adjunct to smoking cessation in Hispanics. Design: Randomized, double-blind, placebo-controlled pilot clinical trial. Intervention: Nicotine or placebo transdermal system (patch) and brief individual motivational support. Results: Six-week abstinence rates in the nicotine versus placebo groups were 63 versus 35%, respectively, and were 46 versus 26%, respectively, at 10 weeks. These differences in abstinence rates between the two groups were significant at 6 weeks (x2 = 7.26, p <0.01) and 10 weeks (x2 = 4.01, p = 0.05). Withdrawal symptoms were not suppressed, though weight was suppressed, in the transdermal nicotine group.

Original languageEnglish (US)
Pages (from-to)304-311
Number of pages8
JournalAmerican Journal of Health Behavior
Volume20
Issue number5
StatePublished - Dec 1 1996

Fingerprint

Nicotine
Hispanic Americans
nicotine
Placebos
Transdermal Patch
Substance Withdrawal Syndrome
Group
Controlled Clinical Trials
Smoking Cessation
Therapeutics
withdrawal
smoking
Weights and Measures

ASJC Scopus subject areas

  • Health(social science)
  • Social Psychology
  • Public Health, Environmental and Occupational Health

Cite this

The Effects of Transdermal Nicotine for the Treatment of Hispanic Smokers. / Leischow, Scott; Hill, Anabel; Cook, Gretchen.

In: American Journal of Health Behavior, Vol. 20, No. 5, 01.12.1996, p. 304-311.

Research output: Contribution to journalArticle

@article{02dc11b3ce09475294024ffc0f46a000,
title = "The Effects of Transdermal Nicotine for the Treatment of Hispanic Smokers",
abstract = "Objective: To assess the efficacy of transdermal nicotine as an adjunct to smoking cessation in Hispanics. Design: Randomized, double-blind, placebo-controlled pilot clinical trial. Intervention: Nicotine or placebo transdermal system (patch) and brief individual motivational support. Results: Six-week abstinence rates in the nicotine versus placebo groups were 63 versus 35{\%}, respectively, and were 46 versus 26{\%}, respectively, at 10 weeks. These differences in abstinence rates between the two groups were significant at 6 weeks (x2 = 7.26, p <0.01) and 10 weeks (x2 = 4.01, p = 0.05). Withdrawal symptoms were not suppressed, though weight was suppressed, in the transdermal nicotine group.",
author = "Scott Leischow and Anabel Hill and Gretchen Cook",
year = "1996",
month = "12",
day = "1",
language = "English (US)",
volume = "20",
pages = "304--311",
journal = "American Journal of Health Behavior",
issn = "1087-3244",
publisher = "PNG Publications",
number = "5",

}

TY - JOUR

T1 - The Effects of Transdermal Nicotine for the Treatment of Hispanic Smokers

AU - Leischow, Scott

AU - Hill, Anabel

AU - Cook, Gretchen

PY - 1996/12/1

Y1 - 1996/12/1

N2 - Objective: To assess the efficacy of transdermal nicotine as an adjunct to smoking cessation in Hispanics. Design: Randomized, double-blind, placebo-controlled pilot clinical trial. Intervention: Nicotine or placebo transdermal system (patch) and brief individual motivational support. Results: Six-week abstinence rates in the nicotine versus placebo groups were 63 versus 35%, respectively, and were 46 versus 26%, respectively, at 10 weeks. These differences in abstinence rates between the two groups were significant at 6 weeks (x2 = 7.26, p <0.01) and 10 weeks (x2 = 4.01, p = 0.05). Withdrawal symptoms were not suppressed, though weight was suppressed, in the transdermal nicotine group.

AB - Objective: To assess the efficacy of transdermal nicotine as an adjunct to smoking cessation in Hispanics. Design: Randomized, double-blind, placebo-controlled pilot clinical trial. Intervention: Nicotine or placebo transdermal system (patch) and brief individual motivational support. Results: Six-week abstinence rates in the nicotine versus placebo groups were 63 versus 35%, respectively, and were 46 versus 26%, respectively, at 10 weeks. These differences in abstinence rates between the two groups were significant at 6 weeks (x2 = 7.26, p <0.01) and 10 weeks (x2 = 4.01, p = 0.05). Withdrawal symptoms were not suppressed, though weight was suppressed, in the transdermal nicotine group.

UR - http://www.scopus.com/inward/record.url?scp=0030518737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030518737&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0030518737

VL - 20

SP - 304

EP - 311

JO - American Journal of Health Behavior

JF - American Journal of Health Behavior

SN - 1087-3244

IS - 5

ER -